525 related articles for article (PubMed ID: 25156572)
1. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive metabolomic study of platelets reveals the expression of discrete metabolic phenotypes during storage.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Valgeirsdottir S; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2014 Nov; 54(11):2911-23. PubMed ID: 24840017
[TBL] [Abstract][Full Text] [Related]
3. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
4. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer.
Wagner SJ; Seetharaman S; Kurtz J
Transfusion; 2012 Nov; 52(11):2427-31. PubMed ID: 22452313
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
Charania R; Smith J; Vesely SK; Dale GL; Holter J
Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
[TBL] [Abstract][Full Text] [Related]
7. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
Singh S; Shams Hakimi C; Jeppsson A; Hesse C
Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
[TBL] [Abstract][Full Text] [Related]
8. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
9. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
10. Increasing susceptibility of nitric oxide-mediated inhibitory platelet signaling during storage of apheresis-derived platelet concentrates.
Kobsar A; Klinker E; Kuhn S; Koessler A; Yilmaz P; Boeck M; Koessler J
Transfusion; 2014 Jul; 54(7):1782-9. PubMed ID: 24576258
[TBL] [Abstract][Full Text] [Related]
11. Systems analysis of metabolism in platelet concentrates during storage in platelet additive solution.
Jóhannsson F; Guðmundsson S; Paglia G; Guðmundsson S; Palsson B; Sigurjónsson ÓE; Rolfsson Ó
Biochem J; 2018 Jul; 475(13):2225-2240. PubMed ID: 29914982
[TBL] [Abstract][Full Text] [Related]
12. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
13. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.
Gravemann U; Volgmann T; Min K; Philipp R; Lambrecht B; Müller TH; Seltsam A
Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
[TBL] [Abstract][Full Text] [Related]
16. Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
Bertaggia Calderara D; Crettaz D; Aliotta A; Barelli S; Tissot JD; Prudent M; Alberio L
Transfusion; 2018 Oct; 58(10):2395-2406. PubMed ID: 30229925
[TBL] [Abstract][Full Text] [Related]
17. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
Radwanski K; Min K
Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
[TBL] [Abstract][Full Text] [Related]
18. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
